TABLE 1.
mRNAs enriched in pulldown and increased in knockdown of KSRPa
| RefSeq accession no. | Description | Gene name | mRNA status
|
ARE classd | |
|---|---|---|---|---|---|
| Unstableb | Stabilized in KSRP knockdownc | ||||
| NM_001200 | Bone morphogenetic protein 2 (BMP2), mRNA | BMP2 | + | + | |
| NM_000758 | Colony stimulating factor 2 (granulocyte-macrophage) (CSF2), mRNA | CSF2 | + | + | II |
| NM_002089 | Chemokine (C-X-C motif) ligand 2 (CXCL2), mRNA | CXCL2 | + | + | II |
| NM_002090 | Chemokine (C-X-C motif) ligand 3 (CXCL3), mRNA | CXCL3 | + | + | II |
| NM_018948 | ERBB receptor feedback inhibitor 1 (ERRFI1), mRNA | ERRFI1 | + | + | |
| NM_004864 | Growth differentiation factor 15 (GDF15), mRNA | GDF15 | + | + | II |
| NM_002166 | Inhibitor of DNA binding 2, dominant negative helix-loop-helix protein (ID2), mRNA | ID2 | + | + | I |
| NM_000600 | Interleukin 6 (beta 2 interferon, beta 2) (IL6), mRNA | IL6 | + | + | I |
| NM_000584 | Interleukin 8 (IL8), mRNA | IL8 | + | + | II |
| NM_000963 | Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (PTGS2), mRNA | PTGS2 | + | + | II |
| NM_000024 | Adrenergic beta-2-, receptor, surface (ADRB2), mRNA | ADRB2 | + | ||
| NM_016201 | Angiomotin-like 2 (AMOTL2), mRNA | AMOTL2 | + | ||
| NM_025047 | ADP-ribosylation factor-like 14 (ARL14), mRNA | ARL14 | + | I | |
| NM_006577 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 (B3GNT2), mRNA | B3GNT2 | + | I | |
| NM_170735 | Brain-derived neurotrophic factor (BDNF), transcript variant 1, mRNA | BDNF | + | I | |
| NM_001901 | Connective tissue growth factor (CTGF), mRNA | CTGF | + | ||
| NM_001554 | Cysteine-rich angiogenic inducer 61 (CYR61), mRNA | CYR61 | + | ||
| NM_012242 | Dickkopf homolog 1 (Xenopus laevis) (DKK1), mRNA | DKK1 | + | ||
| NM_012266 | DnaJ (Hsp40) homolog, subfamily B, member 5 (DNAJB5), mRNA | DNAJB5 | + | ||
| NM_004419 | Dual specificity phosphatase 5 (DUSP5), mRNA | DUSP5 | + | ||
| NM_001946 | Dual specificity phosphatase 6 (DUSP6), transcript variant 1, mRNA | DUSP6 | + | ||
| NM_004951 | Epstein-Barr virus-induced gene 2 (lymphocyte-specific G protein-coupled receptor) (EBI2), mRNA | EBI2 | + | ||
| NM_001955 | Endothelin 1 (EDN1), mRNA | EDN1 | + | ||
| NM_001956 | Endothelin 2 (EDN2), mRNA | EDN2 | + | I | |
| NM_023037 | Furry homolog (Drosophila) (FRY), mRNA | FRY | + | ||
| NM_005261 | GTP binding protein overexpressed in skeletal muscle (GEM), transcript variant 1, mRNA | GEM | + | ||
| NM_005279 | G protein-coupled receptor 1 (GPR1), mRNA | GPR1 | + | ||
| NM_005328 | Hyaluronan synthase 2 (HAS2), mRNA | HAS2 | + | ||
| NM_001945 | Heparin-binding EGF-like growth factor (HBEGF), mRNA | HBEGF | + | II | |
| NM_182757 | IBR domain-containing 2 (IBRDC2), mRNA | IBRDC2 | + | ||
| NM_001547 | Interferon-induced protein with tetratricopeptide repeats 2 (IFIT2), mRNA | IFIT2 | + | ||
| NM_005544 | Insulin receptor substrate 1 (IRS1), mRNA | IRS1 | + | ||
| NM_000214 | Jagged 1 (Alagille syndrome) (JAG1), mRNA | JAG1 | + | II | |
| NM_031419 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor zeta (NFKBIZ), transcript variant 1, mRNA | NFKBIZ | + | ||
| NM_006186 | Nuclear receptor subfamily 4, group A, member 2 (NR4A2), transcript variant 1, mRNA | NR4A2 | + | I | |
| NM_021127 | Phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1), mRNA | PMAIP1 | + | I | |
| NM_005398 | Protein phosphatase 1, regulatory (inhibitor) subunit 3C (PPP1R3C), mRNA | PPP1R3C | + | ||
| NM_000958 | Prostaglandin E receptor 4 (subtype EP4) (PTGER4), mRNA | PTGER4 | + | I | |
| NM_198965 | Parathyroid hormone-like hormone (PTHLH), transcript variant 1, mRNA | PTHLH | + | I | |
| NM_144593 | Ras homolog enriched in brain-like 1 (RHEBL1), mRNA | RHEBL1 | + | ||
| NM_014575 | Schwannomin interacting protein 1 (SCHIP1), mRNA | SCHIP1 | + | ||
| NM_000450 | Selectin E (endothelial adhesion molecule 1) (SELE), mRNA | SELE | + | II | |
| NM_005842 | Sprouty homolog 2 (Drosophila) (SPRY2), mRNA | SPRY2 | + | I | |
| NM_003222 | Transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) (TFAP2C), mRNA | TFAP2C | + | ||
| NM_000594 | Tumor necrosis factor (TNF, superfamily, member 2) (TNF), mRNA | TNF | + | II | |
| NM_001003818 | Tripartite motif-containing 6 (TRIM6), transcript variant 1, mRNA | TRIM6 | + | ||
| NM_033035 | Thymic stromal lymphopoietin (TSLP), transcript variant 1, mRNA | TSLP | + | I | |
| NM_024640 | yrdC domain-containing (E. coli) (YRDC), mRNA | YRDC | + | ||
| NM_023039 | Ankyrin repeat, family A (RFXANK-like), 2 (ANKRA2), mRNA | ANKRA2 | |||
| NM_001233 | Caveolin 2 (CAV2), transcript variant 1, mRNA | CAV2 | I | ||
| NM_025214 | Coiled-coil domain-containing 68 (CCDC68), mRNA | CCDC68 | I | ||
| NM_004591 | Chemokine (C-C motif) ligand 20 (CCL20), mRNA | CCL20 | |||
| NM_012129 | Claudin 12 (CLDN12), mRNA | CLDN12 | |||
| NM_030627 | Cytoplasmic polyadenylation element binding protein 4 (CPEB4), mRNA | CPEB4 | II | ||
| NM_001912 | Cathepsin L (CTSL), transcript variant 1, mRNA | CTSL | |||
| NM_001565 | Chemokine (C-X-C motif) ligand 10 (CXCL10), mRNA | CXCL10 | |||
| NM_005409 | Chemokine (C-X-C motif) ligand 11 (CXCL11), mRNA | CXCL11 | |||
| NM_000782 | Cytochrome P450, family 24, subfamily A, polypeptide 1 (CYP24A1), nuclear gene encoding mitochondrial protein, mRNA | CYP24A1 | |||
| NM_019885 | Cytochrome P450, family 26, subfamily B, polypeptide 1 (CYP26B1), mRNA | CYP26B1 | |||
| AK026768 | cDNA: FLJ23115 fis, clone LNG07933 | DPY19L1P1 | |||
| NM_022726 | Elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4 (ELOVL4), mRNA | ELOVL4 | I | ||
| NM_001432 | Epiregulin (EREG), mRNA | EREG | I | ||
| NM_144503 | F11 receptor (F11R), transcript variant 4, mRNA | F11R | |||
| NM_001993 | Coagulation factor III (thromboplastin, tissue factor) (F3), mRNA | F3 | II | ||
| NM_020066 | Formin 2 (FMN2), mRNA | FMN2 | |||
| NM_013409 | Follistatin (FST), transcript variant FST344, mRNA | FST | |||
| NM_013372 | Gremlin 1, cysteine knot superfamily, homolog (Xenopus laevis) (GREM1), mRNA | GREM1 | |||
| NM_001548 | Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1), transcript variant 2, mRNA | IFIT1 | |||
| NM_016584 | Interleukin 23, alpha subunit p19 (IL23A), mRNA | IL23A | |||
| NM_002192 | Inhibin, beta A (activin A, activin AB alpha polypeptide) (INHBA), mRNA | INHBA | I | ||
| NM_000210 | Integrin, alpha 6 (ITGA6), mRNA | ITGA6 | |||
| NM_005574 | LIM domain only 2 (rhombotin-like 1) (LMO2), mRNA | LMO2 | |||
| NM_033049 | Mucin 13, cell surface-associated (MUC13), mRNA | MUC13 | |||
| NM_021229 | Netrin 4 (NTN4), mRNA | NTN4 | |||
| NM_002581 | Pregnancy-associated plasma protein A, pappalysin 1 (PAPPA), mRNA | PAPPA | |||
| NM_002607 | Platelet-derived growth factor alpha polypeptide (PDGFA), transcript variant 1, mRNA | PDGFA | |||
| NM_016205 | Platelet-derived growth factor C (PDGFC), mRNA | PDGFC | |||
| NM_006823 | Protein kinase (cyclic AMP-dependent, catalytic) inhibitor alpha (PKIA), transcript variant 6, mRNA | PKIA | |||
| NM_001005377 | Plasminogen activator, urokinase receptor (PLAUR), transcript variant 3, mRNA | PLAUR | I | ||
| NM_000959 | Prostaglandin F receptor (FP) (PTGFR), transcript variant 1, mRNA | PTGFR | |||
| NM_003020 | Secretogranin V (7B2 protein) (SCG5), mRNA | SCG5 | |||
| NM_002998 | Syndecan 2 (heparan sulfate proteoglycan 1, cell surface-associated, fibroglycan) (SDC2), mRNA | SDC2 | |||
| NM_002999 | Syndecan 4 (amphiglycan, ryudocan) (SDC4), mRNA | SDC4 | |||
| NM_006216 | Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 (SERPINE2), mRNA | SERPINE2 | |||
| NM_005025 | Serpin peptidase inhibitor, clade I (neuroserpin), member 1 (SERPINI1), mRNA | SERPINI1 | |||
| NM_203349 | SHC (Src homology 2 domain-containing) family, member 4 (SHC4), mRNA | SHC4 | |||
| NM_003759 | Solute carrier family 4, sodium bicarbonate cotransporter, member 4 (SLC4A4), mRNA | SLC4A4 | |||
| NM_032229 | SLIT and NTRK-like family, member 6 (SLITRK6), mRNA | SLITRK6 | I | ||
| NM_006714 | Sphingomyelin phosphodiesterase, acid-like 3A (SMPDL3A), mRNA | SMPDL3A | |||
| NM_003122 | Serine peptidase inhibitor, Kazal type 1 (SPINK1), mRNA | SPINK1 | |||
| NM_030964 | Sprouty homolog 4 (Drosophila) (SPRY4), mRNA | SPRY4 | I | ||
| NM_015000 | Serine/threonine kinase 38-like (STK38L), mRNA | STK38L | |||
| NM_018423 | Serine/threonine/tyrosine kinase 1 (STYK1), mRNA | STYK1 | I | ||
| NM_003236 | Transforming growth factor alpha (TGFA), mRNA | TGFA | I | ||
| NM_003243 | Transforming growth factor beta receptor III (betaglycan, 300 kDa) (TGFBR3), mRNA | TGFBR3 | |||
| NM_024847 | Transmembrane channel-like 7 (TMC7), mRNA | TMC7 | |||
| NM_003304 | Transient receptor potential cation channel, subfamily C, member 1 (TRPC1), mRNA | TRPC1 | I | ||
| NM_016061 | Yippee-like 5 (Drosophila) (YPEL5), mRNA | YPEL5 | |||
| NM_019006 | Zinc finger, AN1-type domain 6 (ZFAND6), mRNA | ZFAND6 | |||
| NM_003407 | Zinc finger protein 36, C3H type, homolog (mouse) (ZFP36), mRNA | ZFP36 | II | ||
Listed are mRNAs with >2-fold signal intensities in stKSRP pulldown compared to those in stGFP pulldown and >2-fold signal intensities in KSRP knockdown cells compared to those in GFP knockdown cells in two independent assays (for details, see Materials and Methods). Boldface indicates mRNAs destabilized by KSRP.
mRNAs labeled “unstable” (+) decreased to 50% or less at 3 h after actinomycin D addition in GFP knockdown cells in both assays.
For mRNAs labeled “stabilized” (+), the ratio of signal intensities for 3 h of actinomycin D treatment to those at 0 h is >1.33-fold higher for KSRP knockdown than for GFP knockdown cells.
ARE classification was done using the ARED3.0 database search tool (http://rc.kfshrc.edu.sa/ared). ARE-containing as well as unstable mRNAs are highly significantly overrepresented (P < 0.0001, Fisher's exact test).